Reuters logo
3 months ago
BRIEF-Genkyotex announces FDA approval of IND for Phase 2 trial of GKT831 in patients with primary biliary cholangitis
May 3, 2017 / 6:12 AM / 3 months ago

BRIEF-Genkyotex announces FDA approval of IND for Phase 2 trial of GKT831 in patients with primary biliary cholangitis

May 3 (Reuters) - Genkyotex SA:

* Announced on Tuesday it received FDA approval of IND for Phase 2 trial of GKT831 in patients with primary biliary cholangitis Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below